QI XING Trademark

Trademark Overview

On Monday, August 23, 2004, a trademark application was filed for QI XING with the United States Patent and Trademark Office. The USPTO has given the QI XING trademark a serial number of 79009500. The federal status of this trademark filing is SECTION 71 ACCEPTED as of Tuesday, May 9, 2017. This trademark is owned by Guangzhou Pharmaceutical Holdings Limited. The QI XING trademark is filed in the Pharmaceutical Products category with the following description:

Medicines for the treatment of cardiovascular and cerebrovascular diseases and apoplexy, hemiplegia and their sequela; Medicines for treatment of spontaneous and night sweating; Medicines for the treatment of menorrhagia or continuous uterine bleeding; Medicines for the treatment of the symptoms induced by asthenia of the kidney, falling of the spleen to transport and convert, disorder of vital energy; Medicines for the treatment of gastrointestinal diseases; Medicines for treating respiratory disease and asthma; Medicines for the treatment of fever caused by febrile diseases; Medicines for the treatment of acute inflammations, fever, pyogenic infections; Medicines for the treatment of antitussive-cold; Medicines for the treatment of infectious diseases; Medicines for the treatment of bone diseases; Preparation for the relief of pain; Preparations for treating colds; Pharmaceutical products for the treatment of viral and infectious diseases, for the treatment of cancer; Dietetic foods ...
qi xing

General Information

Serial Number79009500
Word MarkQI XING
Filing DateMonday, August 23, 2004
Status706 - SECTION 71 ACCEPTED
Status DateTuesday, May 9, 2017
Registration Number3171659
Registration DateTuesday, November 14, 2006
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, August 29, 2006

Trademark Statements

Indication of Colors claimedColor is not claimed as a feature of the mark.
Goods and ServicesMedicines for the treatment of cardiovascular and cerebrovascular diseases and apoplexy, hemiplegia and their sequela; Medicines for treatment of spontaneous and night sweating; Medicines for the treatment of menorrhagia or continuous uterine bleeding; Medicines for the treatment of the symptoms induced by asthenia of the kidney, falling of the spleen to transport and convert, disorder of vital energy; Medicines for the treatment of gastrointestinal diseases; Medicines for treating respiratory disease and asthma; Medicines for the treatment of fever caused by febrile diseases; Medicines for the treatment of acute inflammations, fever, pyogenic infections; Medicines for the treatment of antitussive-cold; Medicines for the treatment of infectious diseases; Medicines for the treatment of bone diseases; Preparation for the relief of pain; Preparations for treating colds; Pharmaceutical products for the treatment of viral and infectious diseases, for the treatment of cancer; Dietetic foods adapted for medical use; Depurative for body; Fillings for teeth; Radioactive sources and standards for use in nuclear medicine; Gases for medical use; Sanitary sterilizing preparations; Contact lens solutions; Sanitary pads or incontinence pads; chemical conductors for electrocardiograph electrodes; semen for artificial insemination; cultures of microorganisms for medical and veterinary use; food for babies
Translation of Words in MarkThe foreign wording in the mark translates into English as THE ABLAZE STAR.

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, April 22, 2005
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameGUANGZHOU BAIYUNSHAN PHARMACEUTICAL HOLDINGS CO., LTD.
Party Type31 - New Owner After Registration
Legal Entity Type99 - Other
AddressCN
Party NameGuangzhou Pharmaceutical Holdings Limited
Party Type30 - Original Registrant
Legal Entity Type16 - Limited Liability Company
AddressGuangzhou, GD
CN
Party NameGuangzhou Pharmaceutical Holdings Limited
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressGuangzhou, GD
CN
Party NameGuangzhou Pharmaceutical Holdings Limited
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressGuangzhou, GD
CN

Trademark Events

Event DateEvent Description
Thursday, April 21, 2005SN ASSIGNED FOR SECT 66A APPL FROM IB
Friday, April 22, 2005NEW APPLICATION ENTERED
Friday, April 22, 2005ASSIGNED TO EXAMINER
Tuesday, May 10, 2005NON-FINAL ACTION WRITTEN
Thursday, May 12, 2005NON-FINAL ACTION MAILED
Thursday, June 23, 2005REFUSAL PROCESSED BY IB
Monday, October 31, 2005TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, October 31, 2005TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, October 31, 2005CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, November 4, 2005TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, November 30, 2005EXAMINERS AMENDMENT -WRITTEN
Thursday, December 1, 2005EXAMINERS AMENDMENT MAILED
Thursday, December 1, 2005APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, December 2, 2005ASSIGNED TO LIE
Tuesday, December 6, 2005LAW OFFICE PUBLICATION REVIEW COMPLETED
Tuesday, January 3, 2006WITHDRAWN FROM PUB - OG REVIEW QUERY
Wednesday, January 11, 2006PREVIOUS ALLOWANCE COUNT WITHDRAWN
Tuesday, January 24, 2006NON-FINAL ACTION WRITTEN
Tuesday, January 24, 2006NON-FINAL ACTION MAILED
Friday, February 17, 2006TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, February 17, 2006CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, February 22, 2006TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, March 7, 2006TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, March 7, 2006CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, March 9, 2006TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, March 9, 2006APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, March 10, 2006ASSIGNED TO LIE
Monday, March 13, 2006LAW OFFICE PUBLICATION REVIEW COMPLETED
Monday, April 10, 2006WITHDRAWN FROM PUB - OG REVIEW QUERY
Wednesday, April 12, 2006PREVIOUS ALLOWANCE COUNT WITHDRAWN
Monday, May 1, 2006NON-FINAL ACTION WRITTEN
Monday, May 1, 2006NON-FINAL ACTION MAILED
Monday, June 12, 2006TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, June 12, 2006CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, June 16, 2006TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, June 30, 2006APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, July 7, 2006ASSIGNED TO LIE
Friday, July 7, 2006LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, August 9, 2006NOTICE OF PUBLICATION
Tuesday, August 29, 2006PUBLISHED FOR OPPOSITION
Thursday, September 21, 2006NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Thursday, September 21, 2006NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Thursday, October 5, 2006NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Tuesday, November 14, 2006REGISTERED-PRINCIPAL REGISTER
Wednesday, June 13, 2007FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Thursday, June 21, 2007FINAL DISPOSITION PROCESSED
Thursday, June 21, 2007FINAL DISPOSITION NOTICE SENT TO IB
Friday, March 7, 2008FINAL DECISION TRANSACTION PROCESSED BY IB
Tuesday, May 7, 2013TEAS SECTION 71 RECEIVED
Thursday, May 9, 2013TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, May 29, 2013CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Wednesday, May 29, 2013REGISTERED-SEC.71 ACCEPTED
Wednesday, May 29, 2013NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
Friday, February 21, 2014CHANGE OF OWNER RECEIVED FROM IB
Thursday, October 2, 2014INTERNATIONAL REGISTRATION RENEWED
Saturday, November 14, 2015COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED
Wednesday, November 2, 2016TEAS SECTION 71 RECEIVED
Monday, April 17, 2017CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Wednesday, April 19, 2017POST REGISTRATION ACTION MAILED - SEC.71
Thursday, April 27, 2017TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
Tuesday, May 9, 2017REGISTERED-SEC.71 ACCEPTED
Tuesday, May 9, 2017NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
Monday, June 10, 2024NEW REPRESENTATIVE AT IB RECEIVED
Friday, July 5, 2024INTERNATIONAL REGISTRATION RENEWED
Friday, November 14, 2025COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED

Related Keywords

xing treatment medicines diseases infectious fever treating pyogenic infections antitussive inflammations